Protagonist Therapeutics: 2Q Earnings Snapshot

Associated Press
Updated ·1 min read

NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Thursday reported a loss of $19.4 million in its second quarter.

On a per-share basis, the Newark, California-based company said it had a loss of 59 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The biopharmaceutical company posted revenue of $6.2 million in the period.

Protagonist Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $16.45, a rise of 70% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX